DS
PDSB icon

DRW Securities’s PDS Biotechnology PDSB Stock Holding History

DRW Securities’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,001
Closed -$103K – 85
2018
Q2 		$103K Buy
5,001
+2,500
+100% +$52.2K 0.01% 90
2018
Q1 		$59K Buy
+2,501
New +$673K ﹤0.01% 160

Other funds holding PDSB

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

DRW Securities's PDSB Position: Q3 2018 in Review

DRW Securities sold out of PDS Biotechnology (PDSB) in Q3 2018, closing a stake of 5,001 shares — an estimated $103K sold.

DRW Securities first reported a position in PDSB in Q1 2018 and held it in 2 quarters. The position peaked at $103K in Q2 2018. 37 funds tracked by Wall St. Rank hold PDSB as of Q3 2018.

  • DRW Securities reported no remaining PDS Biotechnology position as of Q3 2018 after selling out during the quarter.
  • DRW Securities sold 5,001 PDS Biotechnology shares in Q3 2018, an estimated $103K.
  • DRW Securities first reported a position in PDS Biotechnology in Q1 2018 and held it in 2 quarters.
  • DRW Securities's PDS Biotechnology position peaked at $103K in Q2 2018.
  • 37 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2018.

Based on DRW Securities's 13F filing for Q3 2018, filed 14 Nov 2018.